NU

NeuroMetrix

- NASDAQ:NURO
Last Updated 2021-09-17

LinkedIn Profile

Access NeuroMetrix historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal GICS Sector GICS Industry
nasdaq:nuro 56402 Sep 6th, 2021 12:00AM NeuroMetrix, Inc. 2.4K 58.00 Open Medical Device Sep 5th, 2021 10:54PM Sep 6th, 2021 11:28AM NeuroMetrix is a commercial stage, innovation driven healthcare company combining bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The company maintains an active research effort and has several pipeline programs. The company is located in Waltham, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. For more information, please visit NeuroMetrix.com. NeuroMetrix markets the following products: Quell® Wearable Pain Relief Technology™ Quell is 100% drug free wearable technology that has changed the lives of people suffering with chronic pain. It combines clinical strength neurostimulation to treat pain with an easy-to-use app that helps people manage pain and reclaim their lives. Quell is doctor recommended and designed for people with chronic back pain, arthritic pain, nerve pain, leg and foot pain, among other chronic pain conditions. Quell launched in June 2015 and is now commercially available OTC at www.quellrelief.com. SENSUS® The SENSUS pain therapy device is a prescription neurostimulation device based on TENS for relief of chronic, intractable pain. SENSUS is a convenient and wearable device that offers physicians and their patients a non-narcotic pain relief option as a complement to medications. DPNCheck® DPNCheck is a fast, accurate, and quantitative nerve conduction test that is used to evaluate systemic neuropathies such as diabetic peripheral neuropathy (DPN). It is designed to be used by clinicians at the point-of-care to objectively detect, stage, and monitor DPN. ADVANCE™ System The ADVANCE System is a platform for the performance of nerve conduction studies. ADVANCE is most commonly used with proprietary nerve specific electrode arrays that combine multiple individual electrodes and embedded microelectronic components into a single patient-use disposable unit. Open Consumer health, Tech/wearable devices, Medical devices, Neurotechnology, digital health, pain management, biomedical engineering Open 1000 Winter Street Waltham MA US 02451 Health Care Equipment & Services
nasdaq:nuro 56402 Sep 5th, 2021 12:00AM NeuroMetrix, Inc. 2.4K 58.00 Open Medical Device Sep 5th, 2021 02:53PM Sep 5th, 2021 02:53PM NeuroMetrix is a commercial stage, innovation driven healthcare company combining bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The company maintains an active research effort and has several pipeline programs. The company is located in Waltham, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. For more information, please visit NeuroMetrix.com. NeuroMetrix markets the following products: Quell® Wearable Pain Relief Technology™ Quell is 100% drug free wearable technology that has changed the lives of people suffering with chronic pain. It combines clinical strength neurostimulation to treat pain with an easy-to-use app that helps people manage pain and reclaim their lives. Quell is doctor recommended and designed for people with chronic back pain, arthritic pain, nerve pain, leg and foot pain, among other chronic pain conditions. Quell launched in June 2015 and is now commercially available OTC at www.quellrelief.com. SENSUS® The SENSUS pain therapy device is a prescription neurostimulation device based on TENS for relief of chronic, intractable pain. SENSUS is a convenient and wearable device that offers physicians and their patients a non-narcotic pain relief option as a complement to medications. DPNCheck® DPNCheck is a fast, accurate, and quantitative nerve conduction test that is used to evaluate systemic neuropathies such as diabetic peripheral neuropathy (DPN). It is designed to be used by clinicians at the point-of-care to objectively detect, stage, and monitor DPN. ADVANCE™ System The ADVANCE System is a platform for the performance of nerve conduction studies. ADVANCE is most commonly used with proprietary nerve specific electrode arrays that combine multiple individual electrodes and embedded microelectronic components into a single patient-use disposable unit. Open Consumer health, Tech/wearable devices, Medical devices, Neurotechnology, digital health, pain management, biomedical engineering Open 1000 Winter Street Waltham MA US 02451 Health Care Equipment & Services
nasdaq:nuro 56402 Sep 4th, 2021 12:00AM NeuroMetrix, Inc. 2.4K 58.00 Open Medical Device Sep 3rd, 2021 10:53PM Sep 4th, 2021 01:33PM NeuroMetrix is a commercial stage, innovation driven healthcare company combining bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The company maintains an active research effort and has several pipeline programs. The company is located in Waltham, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. For more information, please visit NeuroMetrix.com. NeuroMetrix markets the following products: Quell® Wearable Pain Relief Technology™ Quell is 100% drug free wearable technology that has changed the lives of people suffering with chronic pain. It combines clinical strength neurostimulation to treat pain with an easy-to-use app that helps people manage pain and reclaim their lives. Quell is doctor recommended and designed for people with chronic back pain, arthritic pain, nerve pain, leg and foot pain, among other chronic pain conditions. Quell launched in June 2015 and is now commercially available OTC at www.quellrelief.com. SENSUS® The SENSUS pain therapy device is a prescription neurostimulation device based on TENS for relief of chronic, intractable pain. SENSUS is a convenient and wearable device that offers physicians and their patients a non-narcotic pain relief option as a complement to medications. DPNCheck® DPNCheck is a fast, accurate, and quantitative nerve conduction test that is used to evaluate systemic neuropathies such as diabetic peripheral neuropathy (DPN). It is designed to be used by clinicians at the point-of-care to objectively detect, stage, and monitor DPN. ADVANCE™ System The ADVANCE System is a platform for the performance of nerve conduction studies. ADVANCE is most commonly used with proprietary nerve specific electrode arrays that combine multiple individual electrodes and embedded microelectronic components into a single patient-use disposable unit. Open Consumer health, Tech/wearable devices, Medical devices, Neurotechnology, digital health, pain management, biomedical engineering Open 1000 Winter Street Waltham MA US 02451 Health Care Equipment & Services
nasdaq:nuro 56402 Sep 3rd, 2021 12:00AM NeuroMetrix, Inc. 2.4K 58.00 Open Medical Device Sep 3rd, 2021 12:38PM Sep 3rd, 2021 12:38PM NeuroMetrix is a commercial stage, innovation driven healthcare company combining bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The company maintains an active research effort and has several pipeline programs. The company is located in Waltham, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. For more information, please visit NeuroMetrix.com. NeuroMetrix markets the following products: Quell® Wearable Pain Relief Technology™ Quell is 100% drug free wearable technology that has changed the lives of people suffering with chronic pain. It combines clinical strength neurostimulation to treat pain with an easy-to-use app that helps people manage pain and reclaim their lives. Quell is doctor recommended and designed for people with chronic back pain, arthritic pain, nerve pain, leg and foot pain, among other chronic pain conditions. Quell launched in June 2015 and is now commercially available OTC at www.quellrelief.com. SENSUS® The SENSUS pain therapy device is a prescription neurostimulation device based on TENS for relief of chronic, intractable pain. SENSUS is a convenient and wearable device that offers physicians and their patients a non-narcotic pain relief option as a complement to medications. DPNCheck® DPNCheck is a fast, accurate, and quantitative nerve conduction test that is used to evaluate systemic neuropathies such as diabetic peripheral neuropathy (DPN). It is designed to be used by clinicians at the point-of-care to objectively detect, stage, and monitor DPN. ADVANCE™ System The ADVANCE System is a platform for the performance of nerve conduction studies. ADVANCE is most commonly used with proprietary nerve specific electrode arrays that combine multiple individual electrodes and embedded microelectronic components into a single patient-use disposable unit. Open Consumer health, Tech/wearable devices, Medical devices, Neurotechnology, digital health, pain management, biomedical engineering Open 1000 Winter Street Waltham MA US 02451 Health Care Equipment & Services
nasdaq:nuro 56402 Sep 2nd, 2021 12:00AM NeuroMetrix, Inc. 2.4K 58.00 Open Medical Device Sep 2nd, 2021 10:19AM Sep 2nd, 2021 10:19AM NeuroMetrix is a commercial stage, innovation driven healthcare company combining bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The company maintains an active research effort and has several pipeline programs. The company is located in Waltham, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. For more information, please visit NeuroMetrix.com. NeuroMetrix markets the following products: Quell® Wearable Pain Relief Technology™ Quell is 100% drug free wearable technology that has changed the lives of people suffering with chronic pain. It combines clinical strength neurostimulation to treat pain with an easy-to-use app that helps people manage pain and reclaim their lives. Quell is doctor recommended and designed for people with chronic back pain, arthritic pain, nerve pain, leg and foot pain, among other chronic pain conditions. Quell launched in June 2015 and is now commercially available OTC at www.quellrelief.com. SENSUS® The SENSUS pain therapy device is a prescription neurostimulation device based on TENS for relief of chronic, intractable pain. SENSUS is a convenient and wearable device that offers physicians and their patients a non-narcotic pain relief option as a complement to medications. DPNCheck® DPNCheck is a fast, accurate, and quantitative nerve conduction test that is used to evaluate systemic neuropathies such as diabetic peripheral neuropathy (DPN). It is designed to be used by clinicians at the point-of-care to objectively detect, stage, and monitor DPN. ADVANCE™ System The ADVANCE System is a platform for the performance of nerve conduction studies. ADVANCE is most commonly used with proprietary nerve specific electrode arrays that combine multiple individual electrodes and embedded microelectronic components into a single patient-use disposable unit. Open Consumer health, Tech/wearable devices, Medical devices, Neurotechnology, digital health, pain management, biomedical engineering Open 1000 Winter Street Waltham MA US 02451 Health Care Equipment & Services
nasdaq:nuro 56402 Sep 1st, 2021 12:00AM NeuroMetrix, Inc. 2.4K 58.00 Open Medical Device Sep 1st, 2021 09:55AM Sep 1st, 2021 09:55AM NeuroMetrix is a commercial stage, innovation driven healthcare company combining bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The company maintains an active research effort and has several pipeline programs. The company is located in Waltham, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. For more information, please visit NeuroMetrix.com. NeuroMetrix markets the following products: Quell® Wearable Pain Relief Technology™ Quell is 100% drug free wearable technology that has changed the lives of people suffering with chronic pain. It combines clinical strength neurostimulation to treat pain with an easy-to-use app that helps people manage pain and reclaim their lives. Quell is doctor recommended and designed for people with chronic back pain, arthritic pain, nerve pain, leg and foot pain, among other chronic pain conditions. Quell launched in June 2015 and is now commercially available OTC at www.quellrelief.com. SENSUS® The SENSUS pain therapy device is a prescription neurostimulation device based on TENS for relief of chronic, intractable pain. SENSUS is a convenient and wearable device that offers physicians and their patients a non-narcotic pain relief option as a complement to medications. DPNCheck® DPNCheck is a fast, accurate, and quantitative nerve conduction test that is used to evaluate systemic neuropathies such as diabetic peripheral neuropathy (DPN). It is designed to be used by clinicians at the point-of-care to objectively detect, stage, and monitor DPN. ADVANCE™ System The ADVANCE System is a platform for the performance of nerve conduction studies. ADVANCE is most commonly used with proprietary nerve specific electrode arrays that combine multiple individual electrodes and embedded microelectronic components into a single patient-use disposable unit. Open Consumer health, Tech/wearable devices, Medical devices, Neurotechnology, digital health, pain management, biomedical engineering Open 1000 Winter Street Waltham MA US 02451 Health Care Equipment & Services
nasdaq:nuro 56402 Aug 31st, 2021 12:00AM NeuroMetrix, Inc. 2.4K 59.00 Open Medical Device Aug 31st, 2021 09:49AM Aug 31st, 2021 09:49AM NeuroMetrix is a commercial stage, innovation driven healthcare company combining bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The company maintains an active research effort and has several pipeline programs. The company is located in Waltham, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. For more information, please visit NeuroMetrix.com. NeuroMetrix markets the following products: Quell® Wearable Pain Relief Technology™ Quell is 100% drug free wearable technology that has changed the lives of people suffering with chronic pain. It combines clinical strength neurostimulation to treat pain with an easy-to-use app that helps people manage pain and reclaim their lives. Quell is doctor recommended and designed for people with chronic back pain, arthritic pain, nerve pain, leg and foot pain, among other chronic pain conditions. Quell launched in June 2015 and is now commercially available OTC at www.quellrelief.com. SENSUS® The SENSUS pain therapy device is a prescription neurostimulation device based on TENS for relief of chronic, intractable pain. SENSUS is a convenient and wearable device that offers physicians and their patients a non-narcotic pain relief option as a complement to medications. DPNCheck® DPNCheck is a fast, accurate, and quantitative nerve conduction test that is used to evaluate systemic neuropathies such as diabetic peripheral neuropathy (DPN). It is designed to be used by clinicians at the point-of-care to objectively detect, stage, and monitor DPN. ADVANCE™ System The ADVANCE System is a platform for the performance of nerve conduction studies. ADVANCE is most commonly used with proprietary nerve specific electrode arrays that combine multiple individual electrodes and embedded microelectronic components into a single patient-use disposable unit. Open Consumer health, Tech/wearable devices, Medical devices, Neurotechnology, digital health, pain management, biomedical engineering Open 1000 Winter Street Waltham MA US 02451 Health Care Equipment & Services
nasdaq:nuro 56402 Aug 30th, 2021 12:00AM NeuroMetrix, Inc. 2.4K 59.00 Open Medical Device Aug 30th, 2021 10:10AM Aug 30th, 2021 10:10AM NeuroMetrix is a commercial stage, innovation driven healthcare company combining bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The company maintains an active research effort and has several pipeline programs. The company is located in Waltham, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. For more information, please visit NeuroMetrix.com. NeuroMetrix markets the following products: Quell® Wearable Pain Relief Technology™ Quell is 100% drug free wearable technology that has changed the lives of people suffering with chronic pain. It combines clinical strength neurostimulation to treat pain with an easy-to-use app that helps people manage pain and reclaim their lives. Quell is doctor recommended and designed for people with chronic back pain, arthritic pain, nerve pain, leg and foot pain, among other chronic pain conditions. Quell launched in June 2015 and is now commercially available OTC at www.quellrelief.com. SENSUS® The SENSUS pain therapy device is a prescription neurostimulation device based on TENS for relief of chronic, intractable pain. SENSUS is a convenient and wearable device that offers physicians and their patients a non-narcotic pain relief option as a complement to medications. DPNCheck® DPNCheck is a fast, accurate, and quantitative nerve conduction test that is used to evaluate systemic neuropathies such as diabetic peripheral neuropathy (DPN). It is designed to be used by clinicians at the point-of-care to objectively detect, stage, and monitor DPN. ADVANCE™ System The ADVANCE System is a platform for the performance of nerve conduction studies. ADVANCE is most commonly used with proprietary nerve specific electrode arrays that combine multiple individual electrodes and embedded microelectronic components into a single patient-use disposable unit. Open Consumer health, Tech/wearable devices, Medical devices, Neurotechnology, digital health, pain management, biomedical engineering Open 1000 Winter Street Waltham MA US 02451 Health Care Equipment & Services
nasdaq:nuro 56402 Aug 29th, 2021 12:00AM NeuroMetrix, Inc. 2.4K 59.00 Open Medical Device Aug 29th, 2021 04:17PM Aug 29th, 2021 04:17PM NeuroMetrix is a commercial stage, innovation driven healthcare company combining bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The company maintains an active research effort and has several pipeline programs. The company is located in Waltham, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. For more information, please visit NeuroMetrix.com. NeuroMetrix markets the following products: Quell® Wearable Pain Relief Technology™ Quell is 100% drug free wearable technology that has changed the lives of people suffering with chronic pain. It combines clinical strength neurostimulation to treat pain with an easy-to-use app that helps people manage pain and reclaim their lives. Quell is doctor recommended and designed for people with chronic back pain, arthritic pain, nerve pain, leg and foot pain, among other chronic pain conditions. Quell launched in June 2015 and is now commercially available OTC at www.quellrelief.com. SENSUS® The SENSUS pain therapy device is a prescription neurostimulation device based on TENS for relief of chronic, intractable pain. SENSUS is a convenient and wearable device that offers physicians and their patients a non-narcotic pain relief option as a complement to medications. DPNCheck® DPNCheck is a fast, accurate, and quantitative nerve conduction test that is used to evaluate systemic neuropathies such as diabetic peripheral neuropathy (DPN). It is designed to be used by clinicians at the point-of-care to objectively detect, stage, and monitor DPN. ADVANCE™ System The ADVANCE System is a platform for the performance of nerve conduction studies. ADVANCE is most commonly used with proprietary nerve specific electrode arrays that combine multiple individual electrodes and embedded microelectronic components into a single patient-use disposable unit. Open Consumer health, Tech/wearable devices, Medical devices, Neurotechnology, digital health, pain management, biomedical engineering Open 1000 Winter Street Waltham MA US 02451 Health Care Equipment & Services
nasdaq:nuro 56402 Aug 28th, 2021 12:00AM NeuroMetrix, Inc. 2.4K 59.00 Open Medical Device Aug 28th, 2021 02:50PM Aug 28th, 2021 02:50PM NeuroMetrix is a commercial stage, innovation driven healthcare company combining bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The company maintains an active research effort and has several pipeline programs. The company is located in Waltham, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. For more information, please visit NeuroMetrix.com. NeuroMetrix markets the following products: Quell® Wearable Pain Relief Technology™ Quell is 100% drug free wearable technology that has changed the lives of people suffering with chronic pain. It combines clinical strength neurostimulation to treat pain with an easy-to-use app that helps people manage pain and reclaim their lives. Quell is doctor recommended and designed for people with chronic back pain, arthritic pain, nerve pain, leg and foot pain, among other chronic pain conditions. Quell launched in June 2015 and is now commercially available OTC at www.quellrelief.com. SENSUS® The SENSUS pain therapy device is a prescription neurostimulation device based on TENS for relief of chronic, intractable pain. SENSUS is a convenient and wearable device that offers physicians and their patients a non-narcotic pain relief option as a complement to medications. DPNCheck® DPNCheck is a fast, accurate, and quantitative nerve conduction test that is used to evaluate systemic neuropathies such as diabetic peripheral neuropathy (DPN). It is designed to be used by clinicians at the point-of-care to objectively detect, stage, and monitor DPN. ADVANCE™ System The ADVANCE System is a platform for the performance of nerve conduction studies. ADVANCE is most commonly used with proprietary nerve specific electrode arrays that combine multiple individual electrodes and embedded microelectronic components into a single patient-use disposable unit. Open Consumer health, Tech/wearable devices, Medical devices, Neurotechnology, digital health, pain management, biomedical engineering Open 1000 Winter Street Waltham MA US 02451 Health Care Equipment & Services

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.